BioLytical Laboratories Inc. Announces Launch of Its INSTI® HCV Antibody Test for Professional Use in Australia

bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG number: 448926) The screening test is portable and can be used as an aid in diagnosis for detection of [...]